Under construction – not a live service
Sign in

2025-520571-66-00RecruitingPhase 3

CYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids.

Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Jun 2026

Next steps

Brief summary (registry, in English)

To assess the extent to which the antiandrogens (enzalutamide and apalutamide) influence the pharmacokinetics of the administered corticosteroid dexamethasone.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
30 (estimated)
First submitted
19 Nov 2025
Start date
30 Jun 2026
Lead sponsor
Region Vaesterbotten
EU CT number
2025-520571-66-00

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 30
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Treatment with systemic corticosteroids (ongoing or last 4 weeks), inhalations steroids, topical steroids or nasal steroids are not regarded as systemic therapies
  • Treatment with health product modulating CYP3A4
  • Treatment with warfarin or NOAC (Non-vitamin K-antagonist anticoagulants)
  • Previous seizure in medical history

Other illness

  • Diabetes (defined as diagnosed diabetes type I or type II)
  • Other serious illness or medical condition according to the investigator, e.g., other cancer, history of peptic ulcer, or bipolar disorder.

Who the study is looking for

  • Diagnosed prostate cancer
  • Intended to begin treatment with antiandrogen therapy, -enzalutamide or apalutamide-
  • Can understand all the requirements of the trial, provide informed consent, and provide authorization of use and disclosure of personal health information
  • WHO performance status 0-1

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Region VaesterbottenUmeaSwedenRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.